Nivolumab with ipilimumab for treating squamous cell carcinoma of the head and neck [ID1355]
Discontinued
Reference number: GID-TA10321
As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of nivolumab with ipilimumab for treating squamous cell carcinoma of the head and neck.
Following on from advice received from the company the timelines for this appraisal are to be aligned with the latest regulatory expectations and further information regarding the scheduling of this appraisal will be available in due course.